Regulation of the Pharmaceutical Industry in Côte d'Ivoire and alignment with community development policies: realities and prospects for 2025
Abstract
The Regional Pharmaceutical Plan of ECOWAS (PPRC) was adopted in 2014 by to address the insufficient development of local pharmaceutical industry (IP) with a desired impact to be seen by 2025. We appreciated the level of adequacy of the political and regulatory measures taken in Côte d’Ivoire, one Member State, to implement it. The Government recently identifies the PI cluster among the three priority since the five-year term 2021-2025. Various plans, but only a specific one, exist in Côte d’Ivoire in line with the desired industrialization. As for the specific legal framework, it hasn’t undergone much change since 2014. Nevertheless, in terms of institutional governance, a service dedicated to its promotion has been created into the Ministry of Health by Ministerial Order in April 2025.
Conclusion: There is a certain adequation between policies, regulatory and PPRC as well as good perspectives. That must be optimized in a global industrialization plan and the adoption of texts allowing it.
Downloads
References
2. Economic Community of West African States (ECOWAS). 2014–2020 ECOWAS Regional Pharmaceutical Plan (PPRC). Bobo-Dioulasso: WAHO; 2014.
3. Republic of Côte d'Ivoire. The national pharmaceutical policy of Côte d'Ivoire. Abidjan: Ministry of Health, Public Hygiene and Universal Health Coverage; 2023.
4. Alloukou-Boka PM. Sub-regional economic organisations in the development of pharmaceutical regulation: the case of West Africa [Thesis]. Strasbourg: University of Strasbourg, Faculty of Pharmacy; 2018.
5. Economic Community of West African States (ECOWAS). Harmonised TRIPS-related policy for adoption by ECOWAS Member States using TRIPS flexibilities to improve access to medicines in the region. Bobo-Dioulasso: WAHO; 2012.
6. United Nations Industrial Development Organisation - Côte d'Ivoire (UNIDO-CI). Roadmap for Good Manufacturing Practices (GMP) in the ECOWAS region [Internet]. Côte d'Ivoire: UNIDO-CI;2024 [cited 2026 Jan 22]. Available from:
https://onudi.ci/feuille-de-route-des-bonnes-pratiques-de-fabrication-bpf-pharmaceutique-dans-la-cedeao/
7. Economic Community of West African States (ECOWAS). Common Industrial Policy for West Africa (PICAO). Bobo-Dioulasso: WAHO; 2010.
8. Economic Community of West African States (ECOWAS). Abidjan Declaration for the industrialisation of the pharmaceutical sector in West Africa through centres of excellence. Bobo-Dioulasso: OOAS; 2019.
9. Republic of Côte d'Ivoire. National Strategic Plan for the Development of the Local Pharmaceutical Industry 2013-2015. Abidjan: Ministry of Health and AIDS Control; 2012.
10. Republic of Côte d'Ivoire. New industrial policy of Côte d'Ivoire - Phase I: Diagnosis of the industrial sector and institutional framework. Abidjan: Ministry of Industry; 2012.
11. Republic of Côte d'Ivoire. Stakeholder Participation Plan (P3P) – Programme for Diversification, Industrial Acceleration, Competitiveness and Employment. Abidjan: Ministry of Trade and Industry; 2025.
12. Republic of Côte d'Ivoire. National Development Plan 2021-2025. Abidjan: Ministry of Planning and Development; 2021.
13. General Confederation of Enterprises of Côte d'Ivoire (CGECI). The industrialisation of Côte d'Ivoire. White paper. Long version. Abidjan: CGECI; 2019.
14. Republic of Côte d'Ivoire. 2021-2025 National Health Development Plan. Abidjan: Ministry of Health, Public Hygiene and Universal Health Coverage; 2021.
15. Republic of Côte d'Ivoire. 2016-2020 National Health Development Plan. Abidjan: Ministry of Health and AIDS Control; 2016.
16. Republic of Côte d'Ivoire. Ministry of Health and Public Hygiene. Ministerial Order No. 016545/MSPH/MSPH /CAB of 14 September 2017 on the creation, powers, organisation and functioning of the National Working Group on the roadmap initiative for good manufacturing practices for pharmaceutical products; 2017
17. Republic of Côte d'Ivoire. Ministry of Health and AIDS Control. Ministerial Order No. 166/MSLS/CAB of 26 September 2015 establishing the powers, organization and functioning of the Directorate of Pharmacy; 2015
18. Republic of Côte d'Ivoire. Law No. 2017-541 of 3 August 2017 on the regularization of the pharmaceutical sector; 2017
19. Republic of Côte d'Ivoire. Ministry of Health, Public Hygiene and Universal Health Coverage. Ministerial Order No. 339/MSHPCMU/CAB of 24 April 2025 on the powers, organization and functioning of the Directorate of Pharmaceutical Activity; 2025
20. Republic of Côte d'Ivoire. Law No. 2015-533 of 20 July 2015 on the practice of pharmacy; 2015
21. Republic of Côte d'Ivoire. Ministry of Public Health Public. Ministerial Order No. 173/MSP/DSPH/ of 18 April 1986 on the procedures for opening pharmaceutical industry establishments; 1986
22. West African Economic and Monetary Union (UEMOA). Decision No. 08/2010/CM/UEMOA of 1 October 2010 adopting the Guide to Good Manufacturing Practices for Pharmaceutical Products for Human Use in UEMOA Member States;2010
23. Amonkou-N'guessan AC, Amari AS, Alloukou PM, Pabst JY. Descriptive study of the regulations governing the pharmaceutical industry applicable in Côte d'Ivoire. Revue Droit et Santé. 2018; No. 84: 553-564.
24. Republic of Côte d'Ivoire. Decree No. 2015-602 of 2 September 2015 establishing fees for the marketing authorisation of medicinal products;2015
25. Republic of Côte d'Ivoire. Ministry of Health and Social Welfare, Ministry of Industry and Trade, Ministry of Employment and the Civil Service. Interministerial Order No. 101/MSPAS/MIC/MEFP/ of 11 April 1994 amending Interministerial Order No. 32 of 14 February 1991 applying national preference to pharmaceutical specialities produced by CIPHARM; 1994
26. French Republic. Relocation of essential medicines. Press kit. Paris: Prime Minister's Office; 2025.
27. Pamela Herd, Donald Moynihan. The impact of administrative burden on the effectiveness of public governance is not inevitable, and ways to remedy it. Public Action. Research and practices. 2019/4; 5: 16–25.
28. People's Democratic Republic of Algeria. Executive Decree No. 25-187 of 13 July 2025 on the organisation of the central administration of the Ministry of Pharmaceutical Industry;2025
29. People's Democratic Republic of Algeria. Executive Decree No. 25-188 of 17 Moharram 1447, corresponding to 13 July 2025, on the organisation of the central administration of the Ministry of Pharmaceutical Industry;2025
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
